OXT and dilated cardiomyopathy: For the DElncRNA target gene enrichment results, the top five pathways were “Oxytocin signaling pathway”, “MAPK signaling pathway”, “Hypertrophic cardiomyopathy”, “Dilated cardiomyopathy”, and “Cardiac muscle contraction” in the Con/F13% group; and “MAPK signaling pathway”, “Adrenergic signaling in cardiomyocytes”, “prion disease”, and “Osteoclast differentiation” in the Con/F40% group (Figure 5B, Table S8).